FDA Okays New Indication for Alirocumab in Homozygous FH FDA Okays New Indication for Alirocumab in Homozygous FH

The FDA approved use of the PCSK9 inhibitor as an add-on therapy in adults with rare homozygous familial hypercholesterolemia.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Cardiology News Alert Source Type: news